Catherine Novack
Stock Analyst at JonesTrading
(0.62)
# 2,992
Out of 4,418 analysts
7
Total ratings
28.57%
Success rate
-11.17%
Average return
Main Sectors:
Top Industries:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RZLT Rezolute | Initiates: Buy | $10 | $2.88 | +247.22% | 1 | Apr 18, 2024 | |
| FEMY Femasys | Maintains: Buy | $7 → $10 | $1.42 | +604.23% | 1 | Mar 20, 2024 | |
| CALC CalciMedica | Initiates: Buy | $22 | $5.64 | +290.07% | 1 | Feb 16, 2024 | |
| KZR Kezar Life Sciences | Downgrades: Hold | n/a | $0.84 | - | 1 | Oct 5, 2023 | |
| PPBT Purple Biotech | Initiates: Buy | $8 | $0.52 | +1,439.94% | 1 | Jul 21, 2023 | |
| OMGA Omega Therapeutics | Initiates: Buy | $11 | $2.16 | +410.44% | 1 | Mar 10, 2023 | |
| DARE Daré Bioscience | Initiates: Buy | $6 | $0.31 | +1,835.48% | 1 | Dec 1, 2022 |
Rezolute
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $2.88
Upside: +247.22%
Femasys
Mar 20, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.42
Upside: +604.23%
CalciMedica
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $5.64
Upside: +290.07%
Kezar Life Sciences
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.84
Upside: -
Purple Biotech
Jul 21, 2023
Initiates: Buy
Price Target: $8
Current: $0.52
Upside: +1,439.94%
Omega Therapeutics
Mar 10, 2023
Initiates: Buy
Price Target: $11
Current: $2.16
Upside: +410.44%
Daré Bioscience
Dec 1, 2022
Initiates: Buy
Price Target: $6
Current: $0.31
Upside: +1,835.48%